发明名称 Ocular iontophoresis device for treatment of glaucoma, has hollow structure that receives active substance contained in medium, with application surface limited by outer line concave towards optical axis of eyeball
摘要 <p>An ocular iontophoresis device comprises a reservoir (20) for storing an active substance (30) such as medication contained in an electrical conductive medium (35) and a hollow structure (21) which is limited by an outer wall (24), where the hollow structure has an outlet defining an application surface (2) that receives a predetermined portion of the surface of an eye ball (500), the outer wall has a constant inclination angle (alpha ) with respect to an optical axis (1) of eye ball, and the application surface is partly limited by an outer line concave towards optical axis of eyeball. ACTIVITY : Ophthalmological. MECHANISM OF ACTION : Beta blocker.</p>
申请公布号 FR2893852(A1) 申请公布日期 2007.06.01
申请号 FR20060000132 申请日期 2006.01.06
申请人 EYEGATE PHARMA SA SOCIETE ANONYME 发明人 ROY PIERRE
分类号 A61N1/30 主分类号 A61N1/30
代理机构 代理人
主权项
地址